TherapeuticsMD, Inc. (TXMD)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in TherapeuticsMD, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

TherapeuticsMD, Inc. (TXMD) has returned 23.93% so far this year and 118.38% over the past 12 months. Over the last ten years, TXMD has returned -39.94% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Dec 11, 2003, TXMD's average daily return is +2.32%, while the average monthly return is +42.48%. At this rate, your investment would double in approximately 0.2 years.

Historically, 42% of months were positive and 58% were negative. The best month was Oct 2011 with a return of +9,900.0%, while the worst month was Aug 2009 at -86.7%. The longest winning streak lasted 12 consecutive months, and the longest losing streak was 9 months.

On a daily basis, TXMD closed higher 32% of trading days. The best single day was Oct 31, 2011 with a return of +9,900.0%, while the worst single day was Aug 24, 2009 at -86.7%.

TherapeuticsMD, Inc. has an annualized alpha of 40555.63%, beta of -2.45, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since December 12, 2003.

• This stock participated in 185.97% of S&P 500 Index downside but only 123.64% of its upside — more exposed to losses than it benefited from rallies.
• Beta of -2.45 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

TXMD ranks 82 for risk / return — in the top 82% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for TherapeuticsMD, Inc. (TXMD) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the TherapeuticsMD, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the TherapeuticsMD, Inc. was 99.89%, occurring on Aug 24, 2011. Recovery took 546 trading sessions.

The current TherapeuticsMD, Inc. drawdown is 99.63%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of TherapeuticsMD, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how TherapeuticsMD, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.